Angina module 6: secondary prevention and treatment

Released4 March 2015     Expires: 04 March 2017      Programme: Angina 2.5 CPD/CME credits

Sponsorship Statement: A Menarini U.K. S.R.L has provided an educational grant for the production of this e-learning programme and an accompanying book for shared use, and has had no further editorial control or input. The views expressed in the programme and accompanying book are solely those of the authors.

Designed to give healthcare professionals a current update on the treatment of angina, this is one of several modules in our angina programme.

Module first published: 06 July 2012
Revised module released: 04 March 2015

2.5 CPD/CME credits

Learning objectives

After completing this module, participants should become:

• Familiar with the principal drugs for secondary prevention and angina treatment
• Understand their mode of action and clinical profle
• Know when to use them appropriately


Dr Henry Purcell, Royal Brompton Hospital, London.
Dr Chris Arden,  GPwSI in Cardiology, Park Surgery, Chandlers Ford, Southampton


2.5 CPD/CME credits, 2.5 hours
BJC Learning has assigned two and a half hours of CPD/CME credit to this module

Endorsed by:

You need to login to take this module

You need to be a registered member to view this page. It's quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.

75 thoughts on “Angina module 6: secondary prevention and treatment”

All rights reserved. No part of this programme may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publishers, Medinews (Cardiology) Limited.

It shall not, by way of trade or otherwise, be lent, re-sold, hired or otherwise circulated without the publisher’s prior consent.

Medical knowledge is constantly changing. As new information becomes available, changes in treatment, procedures, equipment and the use of drugs becomes necessary. The editors/authors/contributors and the publishers have taken care to ensure that the information given in this text is accurate and up to date. Readers are strongly advised to confirm that the information, especially with regard to drug usage, complies with the latest legislation and standards of practice.

Healthcare professionals should consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews (Cardiology) Limited cannot accept responsibility for any errors in prescribing which may occur.